JMKX003142
/ Jemincare
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
April 29, 2025
A Dose-finding Study of JMKX003142 in Treatment of Cardiac Edema
(clinicaltrials.gov)
- P2 | N=160 | Not yet recruiting | Sponsor: Jemincare
New P2 trial • Cardiovascular • Congestive Heart Failure • Heart Failure
January 30, 2025
Trial of JMKX003142 in Participants with Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)
(clinicaltrials.gov)
- P2 | N=135 | Not yet recruiting | Sponsor: Jemincare
New P2 trial • Autosomal Dominant Polycystic Kidney Disease • Genetic Disorders • Nephrology • Polycystic Kidney Disease • Renal Disease
November 01, 2024
A Dose-finding Study of JMKX003142 in Treatment of Renal Edema
(clinicaltrials.gov)
- P2 | N=216 | Not yet recruiting | Sponsor: Jemincare
New P2 trial
October 28, 2024
Study to Evaluate the Drug-drug Interaction of JMKX003142 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=48 | Not yet recruiting | Sponsor: Jemincare
New P1 trial • Autosomal Dominant Polycystic Kidney Disease • Genetic Disorders • Nephrology • Polycystic Kidney Disease • Renal Disease
April 03, 2024
Study of JMKX003142 Injection in Chinese Healthy Subjects
(clinicaltrials.gov)
- P1 | N=78 | Not yet recruiting | Sponsor: Jemincare
New P1 trial
October 12, 2023
Phase 1 Clinical Study of JMKX003142 Tablets
(clinicaltrials.gov)
- P1 | N=106 | Recruiting | Sponsor: Jemincare
New P1 trial
1 to 6
Of
6
Go to page
1